Treatment-resistant hypertension
Conditions
Interventions
None listed
Sponsors
Fukuoka University
Okamura Clinic,Yamamoto Surgical Hospital,OKAMURA CLINIC,Fukuoka University Faculty of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who performed renal denaturation procedure in clincal trials(A and B study) Patients who have given written consent
Exclusion criteria
Exclusion criteria: Patients who do not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in ABPM before and 5 years after the procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in SBP / DBP of OBP before and 1, 2, 3, 4, and 5 years after the procedure Difference in SBP / DBP of home blood pressure before and 1, 2, 3, 4, and 5 years after the procedure Difference in ABPM SBP / DBP before and 1, 2, 3, 4 and 5 years after the procedure (only when performed in regular clinical practice) Changes in antihypertensive drugs before and 1, 2, 3, 4, and 5 years after the procedure Difference in taking rate of antihypertensive drug before and 1, 2, 3, 4, and 5 years after the procedure Presence or absence of events (cerebral infarction, myocardial infarction, etc.) related to (possibly) hypertension up to 1, 2, 3, 4 or 5 years after the procedure Search for regulatory factors related to BP lowering effect | — |
Countries
Japan
Contacts
Public ContactHideaki Shimada
Fukuoka University Chikushi Hospital Clinical Research Support Center
Outcome results
None listed